The Role of Routine Bacterial Culture Including Tuberculosis During Bronchoscopy: A Prospective Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01167647|
Recruitment Status : Completed
First Posted : July 22, 2010
Last Update Posted : March 6, 2013
|Condition or disease|
Many centers routinely culture bronchoscopy samples for bacteria and mycobacteria even when infections including tuberculosis (TB) are not strongly suspected. However, the value of this practice has been poorly defined. Unnecessary bronchial cultures of bacteria may lead to over treatment in patients without clinical evidence of infections and may increase the drug resistant strains.
In areas with a high prevalence of TB, routine bronchial cultures may detect clinically unsuspected TB in an appreciable proportion of cases. However, in population with a low prevalence of TB, routine culture of bronchial aspirates may incur an unnecessary expanse and may lead to over diagnosis and over treatment of patients with non pathogenic atypical mycobacteria detected by acid-fast bacillus strains.
|Study Type :||Observational|
|Actual Enrollment :||300 participants|
|Official Title:||The Role of Routine Bacterial Culture Including Tuberculosis During|
|Study Start Date :||July 2010|
|Actual Primary Completion Date :||October 2012|
|Actual Study Completion Date :||October 2012|
- number of positive tuberculosis culture [ Time Frame: 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01167647
|Pulmonary department, Meir Medical Center|
|Kfar Saba, Israel, 49100|
|Principal Investigator:||David Shitrit, MD||Meir Medical Center|